The DOI matches its Crossref record; 19 of the 20 references it cites were found in a registry or an index.
Impact of the Lung Allocation Score on Lung Transplantation for Pulmonary Arterial Hypertension
Open accessAbstract
Rationale: In 2005, lung allocation for transplantation in the United States changed from a system based on waiting time to a system based on the Lung Allocation Score (LAS). Objectives: To study the effect of the LAS on lung transplantation for idiopathic pulmonary arterial hypertension (IPAH) compared with other major diagnoses. Methods: We studied 7,952 adults listed for lung transplantation between 2002 and 2008. Analyses were restricted to patients with IPAH, idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD), and cystic fibrosis (CF). Transplantation, waiting list mortality, and post-transplant mortality were compared between diagnoses for patients listed before and after implementation of the LAS. Measurements and Main Results: The likelihood of transplantation from the waiting list increased for all diagnoses after implementation of the LAS. Waiting list mortality decreased for every diagnosis, except for IPAH, which remained unchanged. Implementation of the LAS was not associated with changes in post-transplant mortality for any diagnosis. Under the LAS system, patients with IPAH were less likely to be transplanted than patients with IPF (hazard ratio [HR], 0.53; P < 0.001) or CF (HR, 0.49; P < 0.001) and at greater risk of death on the waiting list than patients with COPD (HR, 3.09; P < 0.001) or CF (HR, 1.83; P = 0.025) after adjustment for demographics and transplant type. Post-transplant mortality for IPAH was not statistically different from that of other diagnoses. Conclusions: Implementation of the LAS has improved the likelihood of lung transplantation for listed patients with IPAH, but mortality on the waiting list remains high compared with other major diagnoses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“This issue is of particular importance in countries where a lung allocation system utilizes a score that does not fully capture the waitlist mortality for individuals with PAH (276–280).”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [276]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In the World Symposium of Pulmonary Hypertension classification of PAH, group 1 is the most common indication.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [59]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Group 2, with decreased left ventricular function, is not an indication for transplantation”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [59]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The current consensus is based on 2 tools for referral and listing: the REVEAL Registry 2.2 (Registry to Evaluate Early and Long-term Pulmonary Arterial Hypertension Disease Management 2.0) and 2015 European Society of Cardiology/European Respiratory Society.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [59]
Experimental — accuracy not yet measuredIn the citing paper
“group 3 with PAH and accompanying pathological changes in the lung parenchyma can be considered for transplantation.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [59]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,960
D'Alonzo, G. E., Barst, R. J., Ayres, S. M., Bergofsky, E. H., Brundage, B. H., Detre, K. M., Fishman, A. P., Goldring, R. M., Groves, B. M., Kernis, J. T., et al. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-5-343 · Cited by 3,501
Long-term intravenous epoprostenol infusion in primary pulmonary hypertension
Sitbon, O., Humbert, M., Nunes, H., Parent, F., Garcia, G., Hervé, P., Rainisio, M., & Simonneau, G. É. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02012-0 · Cited by 1,383
Survival in Primary Pulmonary Hypertension: The Impact of Epoprostenol Therapy
McLaughlin, V. V., Shillington, A., & Rich, S. (2002) · Circulation · doi:10.1161/01.cir.0000029100.82385.58 · Cited by 1,213
Nagaya, N., Nishikimi, T., Uematsu, M., Satoh, T., Kyotani, S., Sakamaki, F., Kakishita, M., Fukushima, K., Okano, Y., Nakanishi, N., et al. (2000) · Circulation · doi:10.1161/01.cir.102.8.865 · Cited by 876
Development of the New Lung Allocation System in the United States
Egan, T. M., Murray, S., Bustami, R. T., Shearon, T. H., McCullough, K. P., Edwards, L. B., Coke, M. A., Garrity, E. R., Sweet, S. C., Heiney, D. A., et al. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01276.x · Cited by 767
Multi-state models for event history analysis
Andersen, P. K., & Keiding, N. (2002) · Statistical Methods in Medical Research · doi:10.1191/0962280202sm276ra · Cited by 628
Rubin, L. J. (2004) · Chest · doi:10.1378/chest.126.1_suppl.7s · Cited by 305
The impact of the lung allocation score on short-term transplantation outcomes: A multicenter study
Kozower, B. D., Meyers, B. F., Smith, M. A., Oliveira, N. C. D., Cassivi, S. D., Guthrie, T. J., Wang, H., Ryan, B. J., Shen, K. R., Daniel, T. M., et al. (2007) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2007.08.044 · Cited by 147
Research works printed but not linked: 3
- 2008, Am J Respir Crit Care Med, 177, A965
- 1988, Ann Stat, 16, 1141
- 2008, J Heart Lung Transplant, 27, S175
Cited by
Leard, L. E., Holm, A. M., Valapour, M., Glanville, A. R., Attawar, S., Aversa, M., Campos, S. V., Christon, L. M., Cypel, M., Dellgren, G., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.07.005 · Cited by 821
Liver Transplantation in the United States, 1999-2008
Thuluvath, P. J., Guidinger, M. K., Fung, J. J., Johnson, L. B., Rayhill, S. C., & Pelletier, S. J. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03037.x · Cited by 574
Lung transplantation for idiopathic pulmonary fibrosis
George, P. M., Patterson, C. M., Reed, A. K., & Thillai, M. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30502-2 · Cited by 297
Causes and Circumstances of Death in Pulmonary Arterial Hypertension
Tonelli, A. R., Arelli, V., Minai, O. A., Newman, J., Bair, N., Heresi, G. A., & Dweik, R. A. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201209-1640oc · Cited by 258
Kotloff, R. M., & Thabut, G. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201101-0134ci · Cited by 257
Metadata
- Authors
- Chen, H., Shiboski, S. C., Golden, J. A., Gould, M. K., Hays, S. R., Hoopes, C. W., & De Marco, T.
- Affiliations
- Division of Pulmonary and Critical Care Medicine
- Department of Epidemiology and Biostatistics
- VA Palo Alto Health Care System (US)
- Division of Adult Cardiothoracic Surgery, and
- Division of Cardiology, University of California, San Francisco, California; and
- Corresponding author
- Chen, Hubert
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-09-01
- Volume
- 180
- Issue
- 5
- Pages
- 468-474
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- PMC
- PMC2742763
- OpenAlex
- W2154735047
- Semantic Scholar
- 1ebd22ede05c3d57834fc012975122dac284eb17
- Cited by
- 161
- References
- 20
- Citations by year
- 2025: 7 · 2024: 3 · 2023: 9 · 2022: 9 · 2021: 10 · 2020: 5 · 2019: 9 · 2018: 11 · 2017: 10 · 2016: 8 · 2015: 8 · 2014: 16 · 2013: 14 · 2012: 14
- FWCI
- 14.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- NHLBI (K23 HL086585)
- NCRR UCSF-CTSI (UL1 RR024131)
- Topics
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Organ Donation and Transplantation
- Keywords
- lung allocation score, lung transplantation, idiopathic pulmonary arterial hypertension, transplant allocation policy, waitlist mortality, post-transplant mortality, idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease, cystic fibrosis, transplant waiting list
- MeSH terms
- Adult, Algorithms, Cystic Fibrosis, Female, Humans, Hypertension, Pulmonary, Male, Middle Aged, Tissue and Organ Procurement, Outcome and Process Assessment, Health Care, Severity of Illness Index, United States, Waiting Lists, Health Care Rationing, Survival Rate, Odds Ratio, Survival Analysis, Lung Transplantation, Age Distribution, Sex Distribution, Patient Selection, Pulmonary Disease, Chronic Obstructive, Idiopathic Pulmonary Fibrosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impact of the Lung Allocation Score on Lung Transplantation for Pulmonary Arterial Hypertension. https://app.cochat.ai/papers/10.1164/rccm.200810-1603oc
- The paper
- Chen, H., Shiboski, S. C., Golden, J. A., Gould, M. K., Hays, S. R., Hoopes, C. W., & De Marco, T. (2009). Impact of the Lung Allocation Score on Lung Transplantation for Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.200810-1603oc
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.